Skip to main content

Table 5 Safety data

From: How effective is tetracaine 4% gel, before a peripherally inserted central catheter, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial [ISRCTN75884221]

Outcome

n

Placebo

n

Tetracaine

Change from baseline in ALT (U/l), median (range)

21

0.0 (-9.0, 20.0)

21

1.0 (-6.0, 10.0)

Change from baseline in creatinine (Ī¼mol/l), median (range)

23

-7.0 (-101.0, 23.0)

23

-6.0 (-30.0, 27.0)

Change from baseline in neutrophil count (x109 /l), median (range)

15

-0.7 (-4.3, 12.3)

13

0.6 (-4.7, 7.6)

Change from baseline in platelet count (x109 /l), median (range)

22

42.0 (-278.0, 260.0)

23

7.0 (-118.0, 202.0)